Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Epidermolysis Bullosa: Corrected iPS Stem Cell-Based Therapy

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
269 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jun 9, 2011

(Part 5 of 6) Marius Wernig, M.D., spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at the CIRM Governing Board meeting on February 4, 2010. Wernig is an assistant professor of pathology at the Institute for Stem Cell Biology and Regenerative Medicine in the Stanford School of Medicine. He is a co-principal investigator on the CIRM Disease Team that is developing a stem cell-based therapy for epidermolysis bullosa. The CIRM-hosted event was presented at the UCSF Mission Bay campus.

To view the other videos in this playlist, go to: http://www.youtube.com/playlist?p=PLE5D21C91186FEEA5

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more